CN Stock MarketDetailed Quotes

688068 Beijing Hotgen Biotech Co.,Ltd

Watchlist

60.88
-0.32-0.52%

Market Closed Dec 27 15:00 CST

5.63BMarket Cap-83.28P/E (TTM)

Beijing Hotgen Biotech Co.,Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Hotgen Biotech Co.,Ltd Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	137.35M	--
		+37.48%
EPS	--	0.03	--
		--

Analyst Rating

Strong Buy

Dec 28, 2024

Beijing Hotgen Biotech Co.,Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 655.000M	--
--	2024/FY	-- / 545.000M	--
--	2019/FY	210.412M / 240.325M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 655.000M--

--2024/FY-- / 545.000M--

--2019/FY210.412M / 240.325M--

--------

Unlock Free Earnings Estimates

Open Account

Beijing Hotgen Biotech Co.,Ltd Earnings Reports

Hejing Biotech: Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024

Oct 31 00:00

Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024

Oct 31 00:00

Beijing Hejing Biotechnology Co., Ltd. 2024 Semi-Annual Report

Aug 30 00:00

Summary of the 2024 semi-annual report of Beijing Hejing Biotechnology Co., Ltd.

Aug 30 00:00

Top CN Stock Gainers

Symbol Price % Chg

Suzhou Industrial Park Heshun Electric

300141

11.14 +20.04%

Guangdong Xiongsu Technology Group

300599

7.67 +20.03%

Sichuan Chuanhuan Technology

300547

24.41 +20.01%

Shanghai Wisdom Information Technology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 28, 2024

Strong Buy

Strong Buy
50.00%
Buy
50.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

The Concept of in Vitro Diagnosis